Advanced imaging technology for better assessment of pancreatic cancer
Patient-specific, high-sensitivity spectral CT for assessment of pancreatic cancer
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-10906242
This study is testing a new imaging technique that helps doctors see and measure iodine levels in pancreatic tumors more clearly, which could improve how they diagnose and treat pancreatic cancer.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10906242 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a high-sensitivity spectral CT imaging technique that can accurately measure iodine concentration in tissues, particularly for pancreatic cancer. By improving the ability to visualize and quantify low-enhancing lesions, this technology aims to enhance diagnosis, staging, and treatment assessment of pancreatic tumors. The approach combines functional and structural imaging to provide comprehensive insights into the tumor microenvironment, which is crucial for effective clinical decision-making. The project addresses challenges associated with traditional imaging methods that often struggle with quantitation bias.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic cancer who require advanced imaging for treatment assessment.
Not a fit: Patients with pancreatic cancer who are not undergoing imaging or those with early-stage disease that does not require advanced imaging techniques may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better treatment planning for patients with pancreatic cancer.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer assessment, indicating that this approach could yield significant advancements in the field.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NOËL, PETER B — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: NOËL, PETER B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.